Flow-injection chemiluminometric determination of some thioxanthene derivatives in pharmaceutical formulations and biological fluids using the [Ru(dipy)3(2+)]-Ce(IV) system.

A flow-injection (FI) methodology using tris(2,2'-dipyridyl)ruthenium(II), [Ru(dipy)3(2+)], chemiluminescence (CL) was developed for the rapid and sensitive determination of three thioxanthene derivatives, namely zuclopenthixol hydrochloride, flupentixol hydrochloride and thiothixene. The method is based on the CL reaction of the studied thioxanthenes with [Ru(dipy)3(2+)] and Ce(IV) in a sulfuric acid medium. Under the optimum conditions, calibration graphs were obtained over the concentration ranges 0.002-6 migrograms/ml for zuclopenthixol hydrochloride, 0.5-15 micrograms/ml for flupentixol hydrochloride and 0.05-7.5 micrograms/ml for thiothixene. The limits of detection (s/n = 3) were 4.2 x 10(-9) mol/l zuclopenthixol hydrochloride, 2 x 10(-8) mol/l flupentixol hydrochloride and 4.5 x 10(-8) mol/l thiothixene. The method was successfully applied to the determination of these compounds in dosage forms and biological fluids.     

Flow-injection chemiluminescent determination of metoclopramide hydrochloride in pharmaceutical formulations and biological fluids using the [Ru(dipy)(3)(2+)]-permanganate system

A flow-injection (FI) methodology using (2,2′-dipyridyl) ruthenium(II) [Ru(dipy)₃²⁺] chemiluminescence (CL) was developed for the rapid and sensitive determination of metoclopramide hydrochloride. The method is based on the CL reaction of metoclopramide with Ru(dipy)₃²⁺ and KMnO₄ in a sulfuric acid medium. Under the optimum conditions, a calibration graph was obtained over the concentration range 0.005-3.5 μg ml⁻¹ with a limit of detection (S/N=2) of 1 ng ml⁻¹. The correlation coefficient was 0.99993 (n=8) with a relative standard deviation of 0.48% for 10 determinations of 1 μg ml⁻¹ of drug. The method was successfully applied to the determination of metoclopramide in pharmaceutical preparations and biological fluids after IP administration of 25 mg kg⁻¹ dose to rats. The elimination half-life was 2.5±0.4 h.     

Chemiluminescence determination of barbituric acid using Ru(phen)(3)(2+)-Ce(IV) system

A chemiluminescence (CL) method for the determination of barbituric acid (BA) was proposed, which is based on the enhancement of BA to the CL intensity of Tris-(1,10-phenanthroline)ruthenium(II) (Ru(phen)₃²⁺)-cerium(IV) (Ce(IV)) system. The concentration of BA is proportional to the CL intensity in the range of 5.0×10⁻³-2.0 μg ml⁻¹. The detection limit is 6.9×10⁻⁴ μg ml⁻¹. The relative standard deviation (R.S.D.) of determining 11 samples containing 0.20 μg ml⁻¹ BA is 3.2%. This CL method has been successfully applied to the determination of BA in the synthetic samples. The mechanism of CL reaction was studied.     

Chemiluminescence Method for the Determination of DNA Using the Ru(bipy)3 2+-Ce(IV) System

 A direct chemiluminescence method for the determination of DNA has been developed. The method is based on the chemiluminescence light produced by the reaction of DNA, Ru(bipy)₃ ²⁺(bipy= 2,2′-bipydyl) and Ce(IV) in sulfuric acid medium. Under the optimum conditions, the response is linearly proportional to the concentration of DNA between 7.0×10⁻⁷ and 5.0×10⁻⁵g ml⁻¹. The final procedure allows the successful determination of DNA in three synthetic samples. This method is simple, rapid and specific. Received January 18, 1999. Revision June 2, 1999.     

钌(II)-联吡啶-铈(IV)-戊二醛化学发光体系及其应用

提出了一种测定戊二醛的新的化学发光分析法.基于在硫酸介质中戊二醛增强铈(IV)氧化钌(II)-联吡啶的化学发光强度.在优化后的条件下,方法的线性范围和检测限分别为2.5×10-6～2.5×10-3 mol/L和3.1×10-7 mol/L戊二醛.拟定的方法体系简单,用于消毒液中戊二醛含量的测定,结果满意.     

钌（Ⅱ）—联吡啶—铈（Ⅳ）—戊二醛化学发光体系及其应用

提出了一种测定戊二醛的新的化学发光分析法.基于在硫酸介质中戊二醛增强铈(IV)氧化钌(II)-联吡啶的化学发光强度.在优化后的条件下,方法的线性范围和检测限分别为2.5×10-6～2.5×10-3 mol/L和3.1×10-7 mol/L戊二醛.拟定的方法体系简单,用于消毒液中戊二醛含量的测定,结果满意.     

A simple and rapid flow injection chemiluminescence determination of cysteine with Ru(phen)3(2+)-Ce(IV) system

A new chemiluminescence system was developed for the determination of cysteine by flow injection system. This method is based on the reaction of L-cysteine with Ru(phen)3(2+) and Ce(IV) to produce chemiluminescence. The calibration curve was linear over the range 8.0x10(-7) to 4.0x10(-5) and 4.0x10(-5) to 1.0x10(-3) M with a detection limit of 7.0x10(-7) M (S/N=3). The relative standard deviation of 4.0x10(-6) M cysteine was found 3.5% (n=10). The influence of potential interfering substances was studied. The proposed method was successfully applied for the flow injection determination of cysteine in the real samples with minimum sampling rate of 90 sample/h.     

Absorption, Circular Dichroism, and Luminescence Spectroscopy of Electrogenerated Delta-[Ru(bipy)(3)](+/0/)(-) and Delta-[Os(bipy)(3)](+/0/)(-) (bipy = 2,2'-Bipyridine)

The electronic absorption and circular dichroism (CD) spectra of the complexes produced by the one, two, and three electron reduction of Delta-[Ru(bipy)(3)](2+) and Delta-[Os(bipy)(3)](2+) are reported. The CD spectra give unequivocal proof that the added electrons are localized on individual bipiridine ligands and thus that the complexes are correctly formulated [M(bipy)(2)(bipy(-))](+), [M(bipy)(bipy(-))(2)](0), and [M(bipy(-))(3)](-). The absorption spectra of the triply reduced species [M(bipy(-))(3)](-) (M = Ru, Os) are compared to those of the Fe(II) and Ir(III) analogs. The luminescence spectra of the two triply reduced complexes [Ru(bipy(-))(3)](-) and [Os(bipy(-))(3)](-). are also presented. The MLCT luminescence found in the parent complexes is completely quenched and is replaced by a weak luminescence attributed to the pi(10) --> pi(7) transition of the (coordinated) [bipy](-) ion.     

A simple and rapid flow-injection chemiluminescence method for the determination of noscapine with Ru(phen)3(2+)-Ce(IV) system

A new flow injection chemiluminescence (CL) system was used for the determination of noscapine. This technique is based on the reduction effect of noscapine on the Ru(phen)3(3+), which is produced by reaction between Ru(phen)3(2+) and acidic Ce(IV) solutions, and this rapid reduction produces strong CL. Calibration plots were linear over the range of 3.0 x 10(-7) - 2.0 x 10(-6) mol L(-1) and 2.0 x 10(-6) - 2.0 x 10(-4) mol L(-1). The CL intensity was so high, that it is able to produce a detection limit of 6.6 x 10(-8) M noscapine (3sigma). The relative standard deviation of 2.0 x 10(-6) M noscapine was 1.0% (n=10). The proposed method was successfully applied for the flow injection determination of noscapine in cough and Tonin syrup samples. The results of real sample analyses show good recovery percentages (97.3-102.4%). The minimum sampling rate was 100 samples per hour.     

Chromatographic analysis of penicillins in pharmaceutical formulations and biological fluids

Natural penicillin (benzylpenicillin) is the oldest antibiotic observed by Alexander Fleming in 1928. To broaden its spectrum of activity, natural penicillin was modified, giving rise to a group of antibiotics under the name 'penicillins'. Although an increasing number of bacteria appear to be resistant to them, penicillins are used to treat a variety of bacterial infections including Gram-positive, Gram-negative aerobic and anaerobic bacteria. Consequently, they are widely used in human and veterinary medicine to prevent and treat diseases. This review covers the analytical methodologies, mainly chromatographic, employed to the penicillins determination in pharmaceutical formulations, biological fluids and in production-scale fermentations reported in the literature. Results of published assays are comparatively presented focusing on sample preparation regarding isolation and purification, chromatographic conditions and method validation. Information on chemical structure, spectrum of activity and action mechanism of common penicillins has also been given.     

Spectrophotometric determination of four macrolide antibiotics in pharmaceutical formulations and biological fluids via binary complex formation with eosin [corrected

A simple, rapid, and sensitive validated spectrophotometric method was developed for the determination of certain macrolide antibiotics namely, erythromycin (I), azithromycin dihydrate (II), clarithromycin (III), and roxithromycin (IV) in bulk powders, pharmaceutical formulations, and spiked biological fluids. The proposed method is based on the formation of a binary complex between each of the studied drugs and eosin Y in aqueous buffered medium. Under the optimum conditions, the binary complexes showed absorption maxima at 542-544 nm. The absorbance of the binary complexes obeyed Beer's law over the concentration range of 1-10 micro/g/mL for II, 2-20 microg/mL for I and IV, and 3-30 microg/mL for III. The mean percentage recoveries were 100.04 +/- 0.83, 99.98 +/- 0.80, 100.17 +/- 0.91, and 99.55 +/- 0.91, with minimum detectable molarities of 2 x 10(-7) for I and II, 4 x 10(-7) for III, and 3 x 10(-7) for IV. The different experimental parameters affecting the development and stability of the colors were studied and optimized. The proposed method was successfully applied to the analysis of the cited drugs in some pharmaceutical formulations. The results obtained were in good agreement with those obtained using the reference methods. The proposed method was further applied to spiked human urine and plasma. A proposal of the reaction pathway is suggested.     

Spectrofluorometric determination of ketorolac tromethamine via its oxidation with cerium(IV) in pharmaceutical preparations and biological fluids

A simple and sensitive fluorometric method for determination of ketorolac tromethamine was studied. The method depends on oxidation of the drug with cerium(IV) and subsequent monitoring of the fluorescence of the induced cerium(III) at lambda(em) 365 nm after excitation at 255 nm. Different variables affecting the reaction conditions, such as the concentrations of cerium(IV), sulfuric acid concentration, reaction time, and temperature, were carefully studied and optimized. Under the optimum conditions, a linear relationship was found between the relative fluorescence intensity and the concentration of the investigated drug in the range of 0.1-0.8 microg/mL. No interferences could be observed from the excipients commonly present in dosage forms. The proposed method was successfully applied to the analysis of the investigated drug in its pure form, pharmaceutical preparations, and biological fluids with good accuracy and precision. The recoveries for pharmaceutical formulations ranged from 99.8-101.0 +/- 0.6% for tablets, 98.5-101.0 +/- 1.0% for ampoules, and 99.0-100.5 +/- 0.7% for eye drops. The results obtained by the proposed method were satisfactory compared with those obtained by the official method. The recoveries for biological fluids were 99.1-100.4 +/- 0.7 and 99.0-100.0 +/- 0.5% for plasma and urine, respectively.     

Chemiluminescence determination of atenolol in biological fluids by a europium-sensitized permanganate-sulfite system

A simple flow injection chemiluminescence (CL) method was developed for the determination of atenolol using Eu³⁺ as the probe. It was found that the weak CL generated by the KMnO₄-Na₂SO₃ reaction can be significantly enhanced by the atenolol-Eu³⁺ complex. The experimental conditions were optimized. The CL intensity was linearly related to atenolol concentration in the range from 8.0 × 10⁻⁹ to 1.0 × 10⁻⁵ g mL⁻¹. The detection limit (3s _b) was 3 × 10⁻⁹ g mL⁻¹ and the relative standard deviation for 1.0 × 10⁻⁷ g mL⁻¹ atenolol solution was 2.4% (n = 11). The method has high sensitivity, wide linear range, inexpensive instrumentation, and has been applied to the determination of atenolol in spiked human urine and plasma samples with recoveries within the range 95.5–104.0%. Supplementary material to this paper is available in electronic form at Electronic supplementary material: Discussion of the reaction mechanism and additional figures are available online as electronic supplementary material (ESM) at . Correspondence: Jianxiu Du, Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry and Materials Science, Shaanxi Normal University, Xi’an 710062, P.R. China     

Substitution reactions of [Ru(dppe)(CO)(H(2)O)(3)][OTf](2)

The labile nature of the coordinated water ligands in the organometallic aqua complex [Ru(dppe)(CO)(H(2)O)(3)][OTf](2) (1) (dppe = Ph(2)PCH(2)CH(2)PPh(2); OTf = OSO(2)CF(3)) has been investigated through substitution reactions with a range of incoming ligands. Dissolution of 1 in acetonitrile or dimethyl sulfoxide results in the facile displacement of all three waters to give [Ru(dppe)(CO)(CH(3)CN)(3)][OTf](2) (2) and [Ru(dppe)(CO)(DMSO)(3)][OTf](2) (3), respectively. Similarly, 1 reacts with Me(3)CNC to afford [Ru(dppe)(CO)(CNCMe(3))(3)][OTf](2) (4). Addition of 1 equiv of 2,2'-bipyridyl (bpy) or 4,4'-dimethyl-2,2'-bipyridyl (Me(2)bpy) to acetone/water solutions of 1 initially yields [Ru(dppe)(CO)(H(2)O)(bpy)][OTf](2) (5a) and [Ru(dppe)(CO)(H(2)O)(Me(2)bpy)][OTf](2) (6a), in which the coordinated water lies trans to CO. Compounds 5a and 6a rapidly rearrange to isomeric species (5b, 6b) in which the ligated water is trans to dppe. Further reactivity has been demonstrated for 6b, which, upon dissolution in CDCl(3), loses water and coordinates a triflate anion to afford [Ru(dppe)(CO)(OTf)(Me(2)bpy)][OTf] (7). Reaction of 1 with CH(3)CH(2)CH(2)SH gives the dinuclear bridging thiolate complex [[(dppe)Ru(CO)](2)(mu-SCH(2)CH(2)CH(3))(3)][OTf] (8). The reaction of 1 with CO in acetone/water is slow and yields the cationic hydride complex [Ru(dppe)(CO)(3)H][OTf] (9) via a water gas shift reaction. Moreover, the same mechanism can also be used to account for the previously reported synthesis of 1 upon reaction of Ru(dppe)(CO)(2)(OTf)(2) with water (Organometallics 1999, 18, 4068).     

Chemiluminescence determination of melatonin and some of its derivatives using potassium permanganate and formaldehyde system

It was found that melatonin and its derivatives, such as N-acetyl- 5-methoxytryptamine (MT), N-acetyl-5-hydroxytryptamine (NAS), 5-Methoxytrypt- amine (5-MT), 5-Methoxyindolyl acetic acid (5-MIAA) and N-acetyl-5-methoxy- 6-hydroxytryptamine (6-HMT) would give chemiluminescence in the acidic potassium permanganate solution, and formaldehyde would enhance this chemiluminescent reaction greatly. The optimum conditions for this chemiluminescent reaction were studied in detail by a flow injection system. A new simple rapid method has been developed under the optimum conditions for determination of melatonin. This method has the advantages of high sensitivity, wide range of linear response and low detection limit. On the basis of investigation of chemiluminescent, fluorescent and UV spectra of melatonin in acidic solution containing potassium permanganate and formaldehyde, a possible mechanism of this reaction was proposed.     

Fluorescence probe enhanced spectrofluorimetric method for the determination of gatifloxacin in pharmaceutical formulations and biological fluids

A spectrofluorimetry for the determination of gatifloxacin (GFLX) was developed based on the strong fluorescence of gatifloxacin after adding fluorescence probe yttrium in buffer solution (pH 7.0) and various factors of influencing fluorescence have been researched. Under the optimum conditions, the liner range was 4.00x10(-8) to 1.00x10(-6)gmL(-1) and the detection limit is 3.36x10(-9)gmL(-1) (correlation coefficient r=0.9997), respectively. The relative standard deviation was 1.1% for 11 measurements of 5.6x10(-7)gmL(-1) gatifloxacin standard solution. The mechanism of sensitizing effect of probe was discussed. The proposed method has been successfully applied to determine real samples and the obtained results are in good agreement with the results of HPLC.     

Syntheses, structural determination, and electrochemistry of Ru(2)(Fap)(4)Cl and Ru(2)(Fap)(4)(NO)Cl

Ru(2)(Fap)(4)Cl and Ru(2)(Fap)(4)(NO)Cl, where Fap is the 2-(2-fluoroanilino)pyridinate anion, were synthesized, and their structural, electrochemical, and spectroscopic properties were characterized. Ru(2)(Fap)(4)Cl, which was obtained by reaction between Ru(2)(O(2)CCH(3))(4)Cl and molten HFap, crystallizes in the monoclinic space group P2(1)/c, with a = 11.2365(4) A, b = 19.9298(8) A, c = 19.0368(7) A, beta = 90.905(1) degrees, and Z = 4. The presence of three unpaired electrons on the Ru(2)(5+) core and the 2.2862(3) A Ru-Ru bond length for Ru(2)(Fap)(4)Cl are consistent with the electronic configuration (sigma)(2)(pi)(4)(delta)(2)(pi*)(2)(delta*)(1). The reaction between Ru(2)(Fap)(4)Cl and NO gas yields Ru(2)(Fap)(4)(NO)Cl, which crystallizes in the orthorhombic space group Pbca, with a = 10.0468(6) A, b = 18.8091(10) A, c = 41.7615(23) A, and Z = 8. The Ru-Ru bond length of Ru(2)(Fap)(4)(NO)Cl is 2.4203(8) A, while its N-O bond length and Ru-N-O bond angle are 1.164(8) A and 155.8(6) degrees, respectively. Ru(2)(Fap)(4)(NO)Cl can be formulated as a formal Ru(2)(II,II)(NO(+)) complex with a linear Ru-N-O group, and the proposed electronic configuration for this compound is (sigma)(2)(pi)(4)(delta)(2)(pi*)(3)(delta*)(1). The binding of NO to Ru(2)(Fap)(4)Cl leads to some structural changes of the Ru(2)(Fap)(4) framework and a stabilization of the lower oxidation states of the diruthenium unit. Also, IR spectroelectrochemical studies of Ru(2)(Fap)(4)(NO)Cl show that NO remains bound to the complex upon reduction and that the first reduction involves the addition of an electron on the diruthenium core and not on the NO axial ligand.     

Synthesis and properties of [Ru(2)(acac)(4)(bptz)](n+) (n=0,1) and crystal structure of [Ru(2)(acac)(4)(bptz)

The neutral complex [Ru(2)(acac)(4)(bptz)] (I) has been prepared by the reaction of Ru(acac)(2)(CH(3)CN)(2) with bptz (bptz = 3,6-bis(2-pyridyl)-1,2,4,5-tetrazine) in acetone. The diruthenium(II,II) complex (I) is green and exhibits an intense metal-ligand charge-transfer band at 700 nm. Complex I is diamagnetic and has been characterized by NMR, optical spectroscopy, IR, and single-crystal X-ray diffraction. Crystal structure data for I are as follows: triclinic, P1, a = 11.709(2) A, b = 13.487(3) A, c = 15.151(3) A, alpha = 65.701(14) degrees, beta = 70.610(14) degrees, gamma = 75.50(2) degrees, V = 2038.8(6) A(3), Z = 2, R = 0.0610, for 4397 reflections with F(o) > 4sigmaF(o). Complex I shows reversible Ru(2)(II,II)-Ru(2)(II,III) and Ru(2)(II,III)-Ru(2)(III,III) couples at 0.17 and 0.97 V, respectively; the 800 mV separation indicates considerable stabilization of the mixed-valence species (K(com) > 10(13)). The diruthenium(II,III) complex, [Ru(2)(acac)(4)(bptz)](PF(6)) (II) is prepared quantitatively by one-electron oxidation of I with cerium(IV) ammonium nitrate in methanol followed by precipitation with NH(4)PF(6). Complex II is blue and shows an intense MLCT band at 575 nm and a weak band at 1220 nm in CHCl(3), which is assigned as the intervalence CT band. The mixed valence complex is paramagnetic, and an isotropic EPR signal at g = 2.17 is observed at 77 and 4 K. The solvent independence and narrowness of the 1200 nm band show that complex II is a Robin and Day class III mixed-valence complex.     

Monomeric oxovanadium(IV) compounds of the general formula cis-[V(IV)(=O)(X)(L(NN))(2)](+/0) [X = OH(-), Cl(-), SO(4)(2)(-) and L(NN) = 2,2'-bipyridine (bipy) or 4,4'-disubstituted bipy

Reaction of [V(IV)OCl(2)(THF)(2)] in aqueous solution with 2 equiv of AgBF(4) or AgSbF(6) and then with 2 equiv of 2,2'-bipyridine (bipy), 4,4'-di-tert-butyl-2,2'-bipyridine (4,4'-dtbipy), or 4,4'-di-methyl-2,2'-bipyridine (4,4'-dmbipy) affords compounds of the general formula cis-[V(IV)O(OH)(L(NN))(2)]Y [where L(NN) = bipy, Y = BF(4)(-) (1), L(NN) = 4,4'-dtbipy, Y = BF(4)(-) (2.1.2H(2)O), L(NN) = 4,4'-dmbipy, Y = BF(4)(-) (3.2H(2)O), and L(NN) = 4,4'-dtbipy, Y = SbF(6)(-) (4)]. Sequential addition of 1 equiv of Ba(ClO(4))(2) and then of 2 equiv of bipy to an aqueous solution containing 1 equiv of V(IV)OSO(4).5H(2)O yields cis-[V(IV)O(OH)(bipy)(2)]ClO(4) (5). The monomeric compounds 1-5 contain the cis-[V(IV)O(OH)](+) structural unit. Reaction of 1 equiv of V(IV)OSO(4).5H(2)O in water and of 1 equiv of [V(IV)OCl(2)(THF)(2)] in ethanol with 2 equiv of bipy gives the compounds cis-[V(IV)O(OSO(3))(bipy)(2)].CH(3)OH.1.5H(2)O (6.CH(3)OH.1.5H(2)O) and cis-[V(IV)OCl(bipy)(2)]Cl (7), respectively, while reaction of 1 equiv of [V(IV)OCl(2)(THF)(2)] in CH(2)Cl(2) with 2 equiv of 4,4'-dtbipy gives the compound cis-[V(IV)OCl(4,4'-dtbipy)(2)]Cl.0.5CH(2)Cl(2) (8.0.5CH(2)Cl(2)). Compounds cis-[V(IV)O(BF(4))(4,4'-dtbipy)(2)]BF(4) (9), cis-[V(IV)O(BF(4))(4,4'-dmbipy)(2)]BF(4) (10), and cis-[V(IV)O(SbF(6))(4,4'-dtbipy)(2)]SbF(6) (11) were synthesized by sequential addition of 2 equiv of 4,4'-dtbipy or 4,4'-dmbipy and 2 equiv of AgBF(4) or AgSbF(6) to a dichloromethane solution containing 1 equiv of [V(IV)OCl(2)(THF)(2)]. The crystal structures of 2.1.2H(2)O, 6.CH(3)OH.1.5H(2)O, and 8.0.5CH(2)Cl(2) were demonstrated by X-ray diffraction analysis. Crystal data are as follows: Compound 2.1.2H(2)O crystallizes in the orthorhombic space group Pbca with (at 298 K) a = 21.62(1) A, b = 13.33(1) A, c = 27.25(2) A, V = 7851(2) A(3), Z = 8. Compound 6.CH(3)OH.1.5H(2)O crystallizes in the monoclinic space group P2(1)/a with (at 298 K) a = 12.581(4) A, b = 14.204(5) A, c = 14.613(6) A, beta = 114.88(1) degrees, V = 2369(1), Z = 4. Compound 8.0.5CH(2)Cl(2) crystallizes in the orthorhombic space group Pca2(1) with (at 298 K) a = 23.072(2) A, b = 24.176(2) A, c = 13.676(1) A, V = 7628(2) A(3), Z = 8 with two crystallographically independent molecules per asymmetric unit. In addition to the synthesis and crystallographic studies, we report the optical, infrared, magnetic, conductivity, and CW EPR properties of these oxovanadium(IV) compounds as well as theoretical studies on [V(IV)O(bipy)(2)](2+) and [V(IV)OX(bipy)(2)](+/0) species (X = OH(-), SO(4)(2)(-), Cl(-)).